11C-Methionine or 11C-Choline PET Is Superior to MRI in the Evaluation of Gliomatosis Cerebri
Authors:
- Shuo GaoSGShuo Gao
- Yansheng LiYLYansheng Li
- Dongyan LuDLDongyan Lu
- 1 February 2011
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 36 (2) , 127-129
Abstract
Gliomatosis cerebri (GC) is a rare neuroepithelial tumor which includes 2 types. Type 1: A 12-year-old boy presented with headache and vomiting. MRI showed the diffuse long T2 signal intensity without enhancement in the right hemisphere. ¹¹C-Methionine PET showed local intense tracer accumulation. Type 2: A 59-year-old woman presented with right hemiparesis and headache. MRI revealed diffuse long T2 signal intensity in multiple lobes, and the left occipital lobe yielded heterogeneous enhancement. ¹¹C-Choline PET showed multiple hypermetabolic foci in the same areas. Our findings show that multiple tracer PET might not only reflect the true extent of GC infiltration but also evaluate GC malignant processes more accurately than MRI.Keywords
This publication has 8 references indexed in Scilit:
- Gliomatosis cerebri: clinicopathologic study of 33 cases and comparison of mass forming and diffuse typesClinical Neuropathology, 2009
- C-11 Choline Versus F-18 Fluorodeoxyglucose for Imaging MeningiomasClinical Nuclear Medicine, 2009
- Metabolic Assessment of Gliomas Using11C-Methionine, [18F] Fluorodeoxyglucose, and11C-Choline Positron-Emission TomographyAmerican Journal of Neuroradiology, 2008
- 1H MR Spectroscopy in the Assessment of Gliomatosis CerebriAmerican Journal of Roentgenology, 2007
- Gliomatosis Cerebri: A Review of 296 Cases from the ANOCEF Database and the LiteratureJournal of Neuro-Oncology, 2005
- Gliomatosis cerebri evaluated by 18F?-methyl tyrosine positron-emission tomographyNeuroradiology, 2003
- CT and MRI findings in gliomatosis cerebri: a neuroradiologic and neuropathologic review of diffuse infiltrating brain neoplasmsEuropean Radiology, 2001
- C-11 Methionine and F-18 FDG Uptake in a Patient With Meningioma and Glioblastoma MultiformeClinical Nuclear Medicine, 1996